Aakha Biologics

Biotechnology Research • United States • 1-10 Employees

Company overview

Headquarters	United States
Website	aakha.bio
NAICS	541714
Employees	1-10
Socials

Key Contact at Aakha Biologics

Hemanta Baruah

Founder & CEO of Aakha Biologics

Aakha Biologics Email Formats

Aakha Biologics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@aakha.bio), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@aakha.bio	66.7%
{first initial}.{last name}	j.doe@aakha.bio	33.3%

About Aakha Biologics

Aakha Biologics is a new kind of biotech company that values efficiency in the drug discovery process to more rapidly bring high quality therapeutics to patients. Aakha is developing biologics that boost the body’s immuno surveillance against tumors and is harnessing multiple advanced antibody discovery platforms to empower its scientists to advance drug candidates from concept to IND-enabling studies. It is led by founder and CEO Hemanta Baruah, a proven drug discoverer with an approved biologic and several additional candidates currently in clinical trials. Aakha was created through a collaborative partnership model with Alloy Therapeutics’ affiliated venture studio 82VS, which leverages access to Alloy’s ATX-Gx™ transgenic mouse, suite of antibody discovery platforms, and discovery services.

Aakha Biologics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding